Weekly round up from Life Sciences Industry.
L3Harris Technologies (NYSE:LHX) has completed the sale of its Narda-MITEQ business to an investment affiliate of J.F. Lehman & Company.
Narda-MITEQ was part of L3Harris’ Aviation Systems segment and provides high performance amplifiers, integrated microwave assemblies, pin diode switches, safety and measurement instrumentation, and other components for use in radiofrequency and microwave systems.
Source: Biospace
Sign up for DistilINFO e-Newsletters.
Novartis bids goodbye to Hudson, hello to new pharma chief Tschudin
Microsoft delves deeper into IoT with Express Logic acquisition
Next-Generation Cloud Storage: Enabling Collaboration & Analytics for Pharma Research
Your Room is Ready: How to Recapture Health System Revenue by Solving “The Motel Problem”
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
PENTIXAPHARM Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics
Former OptumRx CEO Launches Waltz Health with $33M to Lower Drug Costs
AdventHealth Looks To Healthcare Blockchain To Tackle Thorny IT Problems